Living Well With Multiple Myeloma
Exercise and nutrition are important components to long-term health for everyone. But as a myeloma patient, are there specific tips for exercising safely? Can incorporating simple lifestyle changes improve and maintain good bone health? This webinar, featuring physical therapist Melanie House and dietitian Alexa Welch, both from University of Iowa Hospitals and Clinics, will provide guidance for individuals looking to increase their overall health through diet and exercise.
Getting the right cancer care calls for sound, up-to-date information and open dialogue with your healthcare team. As a patient, how do I stay informed about new treatments in development for multiple myeloma? What are the considerations when choosing treatment that’s right for me? In this video, experts will help you better understand the latest multiple myeloma treatments for patients who are actively seeking the best care available.
Patient Cafe® - Multiple Myeloma
Patient Advocate, Cindy Chmielewski (@MyelomaTeacher), leads this Myeloma Patient Café on advocacy opportunities for myeloma patients and care partners and the benefits of them.
Cindy Chmielewski leads a panel of six patients diagnosed with Multiple Myeloma. The panel discusses the symptoms of their disease and some was to cope and manage those side effects.
Cheri Rineker leads a panel of Multiple Myeloma patients who have all participated in a clinical trial. The panel discusses what it's like to join a clinical trial, how they got into a clinical trial, and what it takes to be in a clinical trial.
Town Meeting Videos
Minimal residual disease (MRD) testing is a big topic of interest for many myeloma patients and care partners. What exactly is the role of MRD testing in myeloma, and is it worthwhile?
Watch as Cherie Rineker, a myeloma patient, Dr. Elisabet Manasanch, an oncologist at MD Anderson Cancer Center and Tiffany Richards, an advanced practice nurse, discuss how myeloma is being measured to accurately define myeloma disease states.
Interview with Patient Advocate, Lynette and Robert Orlowski, MD, PhD, Director of Myeloma and Professor in the Departments of Lymphoma/Myeloma and Experimental Therapeutics The University of Texas MD Anderson Cancer Center
Interview with Robert Orlowski, MD, PhD, Director of Myeloma and Professor in the Departments of Lymphoma/Myeloma and Experimental Therapeutics and Tiffany Richards, MS, ANP, AOCNP, Advanced Practice Nurse at The University of Texas MD Anderson Cancer Center and Patient Advocate Lynette
Dr. Elisabet Manasanch, Assistant Professor Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, shares what's the latest and on the horizon for Multiple Myeloma.
Dr. Robert Orlowski, Director of Myeloma and Professor in the Departments of Lymphoma/Myeloma and Experimental Therapeutics at The University of Texas MD Anderson discusses the multiple myeloma highlights and what patients can be excited about from the ASH 2018 meeting.
Dr. Amrita Krishnan, Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, shares the latest news and research that was shared at the ASH 2018 conference in the field of Multiple Myeloma
Dr. Gareth Morgan of The UAMS Myeloma Institute discuss identifying the myeloma genome and what that means for myeloma patients at the American Society of Hematology (ASH) Conference 2017 in Atlanta.